A phase II study of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC)

被引:0
|
作者
Wang, Ting
Huang, Lu Li Lin
Liu, Jie Wei
Zhu, Da Xing
Dong, Jing Si
Deng, Han Yu
Zheng, Xi
Tian, Long
Jiang, Li Li
Wang, Wei Ya
Zhou, Ping
Su, Ming Gang
Pu, Dan
Cai, Xu Yu
Feng, Ming Yang
Ou, Xue Jin
Wang, Yongsheng
Zhou, Qing Hua
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Lung Canc Ctr, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu, Peoples R China
[5] Sichuan Univ, West China Hosp, Ctr Canc, Thorac Oncol Ward, Chengdu, Peoples R China
[6] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8024
引用
收藏
页数:1
相关论文
共 50 条
  • [31] An open-label, prospective, phase II, umbrella study of precise neoadjuvant therapy for patients with stage II-IIIB resectable non-small cell lung cancer (PURPOSE)
    Wang, Y.
    Fang, V.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S989 - S989
  • [32] Neoadjuvant therapy for resectable non-small cell lung cancer
    Welcker, Katrin
    Jonigk, Danny
    Kropf-Sanchen, Cornelia
    Tufman, Amanda
    Draube, Andreas
    Stenzinger, Albrecht
    Zaatar, Mohamed
    Thomas, Michael
    PNEUMOLOGIE, 2025, 79 (01): : 16 - 24
  • [33] Therapy of non-small cell lung cancer in the locally advanced stage (inoperable IIIA/IIIB)
    Baumann, Michael
    Dienemann, Hendrik C.
    Fietkau, Rainer
    Ruebe, Christian
    Thomas, Michael
    ONKOLOGIE, 2006, 29 : 11 - 14
  • [34] Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer
    DeCamp, MM
    Rice, TW
    Adelstein, DJ
    Chidel, MA
    Rybicki, LA
    Murthy, SC
    Blackstone, EH
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (01): : 17 - 27
  • [35] The effects of neoadjuvant chemotherapy with cisplatin and vinorelbine on the resectability of non small cell lung cancer stage IIIA/IIIB
    Spasova, I
    Havel, L
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 591 - 594
  • [36] Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non-small cell lung cancer.
    Ferrer, Loic
    Nadal, Ernest
    Guidel, Floriane
    Insa, Amelia
    Menu, Philippe
    Casal, Joaquin
    Domine, Manuel
    Massuti, Bartomeu
    Majem, Margarita
    Martinez-Marti, Alex
    Garcia Campelo, Rosario
    de Castro Carpeno, Javier
    Cobo, Manuel
    Vivanco, Guillermo Lopez
    del Barco, Edel
    Bernabe, Reyes
    Vinolas, Nuria
    Barneto, Isidoro
    Colin, Thierry
    Provencio-Pulla, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Phase II study of neoadjuvant chemotherapy with paclitaxel and cisplatin in Stage IIIA N2 non-small cell lung cancer.
    Choi, IS
    Oh, DY
    Kim, DW
    Kim, YT
    Kim, TY
    Yoo, CK
    Kim, YW
    Heo, DS
    Bang, YJ
    Kim, NK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 692S - 692S
  • [38] Induction chemotherapy with carboplatin (C), paclitaxel (P) and gemcitabine (G) in unresectable stage IIIA or IIIB non-small cell lung cancer (NSCLC). A phase I-II study
    Novello, G.
    Banna, G. L.
    Restuccia, N.
    Vigneri, P. G.
    Saita, S.
    D'Arrigo, M.
    Pasetto, L. M.
    Buscarino, C.
    Ferrau, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] NEOEAST: A Phase II Study of Ensartinib as Neoadjuvant Therapy for Stage II-IIIB ALK-rearranged Non-small Cell Lung Cancer
    Lu, F. -L.
    Lv, C.
    Zhuo, M. -L.
    Yang, X.
    Yan, S.
    Chen, J. -F.
    Wu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S558 - S558
  • [40] Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer
    Eberhardt, Wilfried
    Gauler, Thomas
    Poettgen, Christoph
    Krbek, Thomas
    Korfee, Soenke
    Stamatis, Georgios
    Stuschke, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) : S35 - S36